Delivery Order SPE2DB20D2104-SPE2DB25FMWPY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Xeljanz XR 11 mg tablets in a quantity of 30 units. This competitively awarded, non-set-aside contract has a ceiling value of $8,389.85 and is structured as a firm fixed price delivery order with an ultimate completion date of August 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $3,914.17 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 18, 2025. The delivery order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Xeljanz 5 mg tablets in quantities of 60 units, with a ceiling value of $6,416.32. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 5, 2025, and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order does not include a set-aside designation and represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $15,662.64, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by July 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $8,141.67, represents a non-competitive set-aside procurement and is scheduled for ultimate completion by August 1, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Xeljanz XR 11 mg tablets (30-count units) with a ceiling value of $3,122.46 and an ultimate completion date of July 31, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with the Defense Logistics Agency. The contractor, headquartered in Conshohocken, Pennsylvania, serves...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,070.63 firm fixed-price delivery order on July 30, 2025, for the supply of Xeljanz 5 mg tablets (60 tablets per unit) under contract number 4568936894. The ultimate completion date is July 31, 2025. This delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $13,132.00 to AmerisourceBergen Drug Corp for the supply of Xeljanz 10 mg tablets (60-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $15,256.14, represents a non-competitive set-aside contract and is scheduled for completion by August 15, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of XELJANZ XR 11 MG tablets in quantities of 30 units, with a ceiling value of $1,889.64. This firm fixed-price delivery order is scheduled for completion by August 11, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting open competition among...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMWPYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units, with a contract ceiling value of $3,212.90. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, medical supplies, and healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs across multiple therapeutic domains, and this Xeljanz order represents a routine fulfillment of pharmaceutical products through the established DLA medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 7/28/25 |